Vivani Medical, Inc. (VANI) News
Track canonical SquawkNews coverage tagged to VANI, Vivani Medical, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Vivani Medical reports Q2 2026 financial results and business update
Vivani Medical (VANI) reports its second quarter 2026 financial results and provides a business update, according to the TradeXchange Newsdesk.
EARNINGS | Aug 13, 2026, 08:06 PM UTC
M
Vivani Medical Completes Dosing In Phase 1 Trial
Vivani Medical completes dosing in phase 1 trial for weight management
EQUITY | Aug 06, 2026, 12:02 PM UTC
H
ClearOne To Acquire Vivani Medical Subsidiary Cortigent For 12.5M Shares Of CLRO Worth ~$40.4M; ClearOne To File S-1 Seeking To Raise $10M-$
Vivani Medical, Inc. (NASDAQ: VANI ) ("Vivani"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that it has entered into a definitive agreement and plan
MNA | Jul 02, 2026, 12:03 PM UTC
M
VANI Receives Approval
Vivani Medical receives regulatory approval for a Phase 1 clinical trial of NPM-139 Semaglutide Implant
EQUITY | Jun 25, 2026, 11:30 AM UTC
L
VANI: CEO to Present at BIO
Vivani Medical CEO Adam Mendelsohn to present at the 2026 BIO International Convention
EARNINGS | Jun 22, 2026, 08:03 PM UTC